Abcam PLC ABCM
We take great care to ensure that the data presented and summarized in this overview for Abcam plc is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ABCM
View all-
Pendal Group LTD1.03MShares$00.13% of portfolio
-
Mario Gabelli Gamco Investors, Inc. Et Al | Rye, Ny41.2KShares$00.01% of portfolio
-
American Portfolios Advisors Holbrook, NY2.16KShares$00.0% of portfolio
-
State Of Wyoming Cheyenne, WY1.37KShares$00.0% of portfolio
-
Fieldpoint Private Securities, LLC60Shares$00.0% of portfolio
-
Wipfli Financial Advisors Llc,1Shares$00.0% of portfolio
Latest Institutional Activity in ABCM
Top Purchases
Top Sells
About ABCM
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
Insider Transactions at ABCM
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|